Adynovate recombinant and Dabrafenib Mesylate
Determining the interaction of Adynovate recombinant and Dabrafenib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Dacarbazine
- Adynovate recombinant-Dacarbazine Intravenous, Injection
- Adynovate recombinant-Daclatasvir
- Adynovate recombinant-Daclatasvir Dihydrochloride
- Adynovate recombinant-Daclizumab
- Adynovate recombinant-Daclizumab Subcutaneous
- Dabrafenib Mesylate-Adzenys ER
- Dabrafenib Mesylate-Adzenys ER Oral Suspension
- Dabrafenib Mesylate-Adzenys XR-ODT
- Dabrafenib Mesylate-Aemcolo
- Dabrafenib Mesylate-Aerobid
- Dabrafenib Mesylate-Aerobid-M